Cargando…

ADA2 deficiency complicated by EBV-driven lymphoproliferative disease

A 29-year old male with recurrent respiratory and skin infections, anaemia and neutropaenia during childhood required immunoglobulin replacement for antibody deficiency from age 16. He remained relatively well until age 28 when he presented with a two-week history of fatigue, sore throat, fever and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Staples, Emily, Simeoni, Ilenia, Stephens, Jonathan C., Allen, Hana Lango, Wright, Penny, Davies, E. Graham, Javid, Babak, Gkrania-Klotsas, Effrossyni, Gattens, Michael, Firth, Helen, Shamardina, Olga, Deevi, Sri V.V., Prapa, Matina, Uttenthal, Ben, Kumararatne, Dinakantha, Thaventhiran, James E.D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academic Press 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306156/ https://www.ncbi.nlm.nih.gov/pubmed/32353633 http://dx.doi.org/10.1016/j.clim.2020.108443

Ejemplares similares

1773. Complement level measurements for children in England suggest a possible unreported Post Streptococcal Glomerulonephritis Outbreak
por: Dale, Rachel, et al.
Publicado: (2023)

Respiratory infectious burden in a cohort of antibody deficiency patients treated with immunoglobulin replacement therapy: The impact of lung pathology and gastroesophageal reflux disease
por: Cutajar, Jonathan, et al.
Publicado: (2023)

Herpes simplex 1 encephalitis presenting as a brain haemorrhage with normal cerebrospinal fluid analysis: a case report
por: Gkrania-Klotsas, Effrossyni, et al.
Publicado: (2008)

Analysis of scoring systems for primary immunodeficiency diagnosis in adult immunology clinics
por: Toms, K., et al.
Publicado: (2020)

1128 Association between Cytomegalovirus Seropositivity or Titres and Cardiovascular Disease: Systematic Review and Meta-Analysis of Prospective Evidence
por: Ali, Mohsin, et al.
Publicado: (2014)

Primary pneumococcal peritonitis can be the first presentation of a familial complement factor I deficiency(1)
por: Ugrinovic, S., et al.
Publicado: (2020)

Influenza: epidemiology and hospital management
por: Tyrrell, Carina SB., et al.
Publicado: (2021)

Procedural confidence in hospital based practitioners: implications for the training and practice of doctors at all grades
por: Connick, Rona M, et al.
Publicado: (2009)

Point of care SARS-CoV-2 nucleic acid testing in schools improves school attendance
por: Collier, Dami A., et al.
Publicado: (2022)

Treatment Advances in EBV Related Lymphoproliferative Diseases
por: Lv, Kebing, et al.
Publicado: (2022)

EBV-Positive T/NK-Cell Lymphoproliferative Disease of Childhood
por: Hong, Mineui, et al.
Publicado: (2013)

Overview of EBV-Associated T/NK-Cell Lymphoproliferative Diseases
por: Kimura, Hiroshi, et al.
Publicado: (2019)

Seropositivity and Higher Immunoglobulin G Antibody Levels Against Cytomegalovirus Are Associated With Mortality in the Population-Based European Prospective Investigation of Cancer–Norfolk Cohort
por: Gkrania-Klotsas, Effrossyni, et al.
Publicado: (2013)

Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders
por: Dugan, James P., et al.
Publicado: (2019)

ESCMID rapid guidelines for assessment and management of long COVID
por: Yelin, Dana, et al.
Publicado: (2022)

Case-report: EBV driven lymphoproliferative disorder associated with Ruxolitinib
por: Pálmason, Róbert, et al.
Publicado: (2015)

Viral-Targeted Strategies Against EBV-Associated Lymphoproliferative Diseases
por: Hui, Kwai Fung, et al.
Publicado: (2019)

Challenges in Managing EBV-Associated T- and NK-Cell Lymphoproliferative Diseases
por: Sato, Yoshitaka
Publicado: (2018)

Immunology of EBV-Related Lymphoproliferative Disease in HIV-Positive Individuals
por: Shindiapina, Polina, et al.
Publicado: (2020)

Characteristic Histological Findings of Asymptomatic EBV-associated Lymphoproliferative Disorders in Tonsils
por: Jamiyan, Tsengelmaa, et al.
Publicado: (2018)

HHV-8 and EBV Positive Lymphoproliferative Disease: A Challenging Case
por: Bülbül, Göksenil, et al.
Publicado: (2022)

New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders
por: Quintanilla-Martinez, Leticia, et al.
Publicado: (2022)

Reference manual for the ADA programming language
por: Barnes, John Gilbert Presslie, et al.
Publicado: (1980)

Epstein-Barr Virus (EBV)-Related Lymphoproliferative Disorders in Ataxia Telangiectasia: Does ATM Regulate EBV Life Cycle?
por: Tatfi, Moussab, et al.
Publicado: (2019)

The First Case of Concomitant Mycobacterium Genavense Lymphadenitis and EBV-Positive Lymphoproliferative Disorder
por: Ito, Yusuke, et al.
Publicado: (2020)

EBV reactivation mimicking a lymphoproliferative disorder associated with ruxolitinib therapy for myelofibrosis
por: Prem, Shruti, et al.
Publicado: (2019)

Risk factors for herpes simplex virus type-1 infection and reactivation: Cross-sectional studies among EPIC-Norfolk participants
por: Forbes, Harriet, et al.
Publicado: (2019)

Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man
Publicado: (1991)

Machine Learning for COVID-19 Diagnosis and Prognostication: Lessons for Amplifying the Signal While Reducing the Noise
por: Driggs, Derek, et al.
Publicado: (2021)

P-glycoprotein is expressed and causes resistance to chemotherapy in EBV-positive T-cell lymphoproliferative diseases
por: Yoshimori, Mayumi, et al.
Publicado: (2015)

EBV-Associated Lymphoproliferative Disorder and Hemophagocytic Lymphohistiocytosis in a Patient with Severe Celiac Disease
por: Kinross-Wright, John Jacob, et al.
Publicado: (2018)

HHV8/EBV Coinfection Lymphoproliferative Disorder: Rare Entity with a Favorable Outcome
por: Bacha, Dhouha, et al.
Publicado: (2017)

Intestinal ulcers as an initial finding in EBV-associated lymphoproliferative disorder: A case report
por: Wang, Sizhu, et al.
Publicado: (2020)

Fatal SARS-CoV-2 coinfection in course of EBV-associated lymphoproliferative disease
por: Roncati, Luca, et al.
Publicado: (2020)

Targeted Delivery of BZLF1 to DEC205 Drives EBV-Protective Immunity in a Spontaneous Model of EBV-Driven Lymphoproliferative Disease
por: Ahmed, Elshafa Hassan, et al.
Publicado: (2021)

EBV-Encoded MicroRNA-BART17-3p Targets DDX3X and Promotes EBV Infection in EBV-Associated T/Natural Killer–Cell Lymphoproliferative Diseases
por: Jin, Jin, et al.
Publicado: (2023)

Highlights: Focus on immunodeficiency-associated lymphoproliferative disorders: Current topics on other iatrogenic immunodeficiency-associated lymphoproliferative disorders and EBV-positive mucocutaneous ulcer
por: Sato, Yasuharu
Publicado: (2019)

Methotrexate-associated lymphoproliferative disorder demonstrating composite lymphoma of EBV-negative diffuse large B-cell lymphoma and EBV-positive mucocutaneous ulcer
por: Moriya, Keiichi, et al.
Publicado: (2020)

Refractory Epstein-Barr Virus (EBV)-Related Post-transplant Lymphoproliferative Disease: Cure by Combined Brentuximab Vedotin and Allogeneic EBV-Specific T-Lymphocytes
por: Mika, Thomas, et al.
Publicado: (2019)

Expression of HSV-1 Receptors in EBV-Associated Lymphoproliferative Disease Determines Susceptibility to Oncolytic HSV
por: Wang, Pin-Yi, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_mnkghn58fj6dcfqnlgsup48007